BEARINGPOINT
1.7.2021 08:37:08 CEST | Business Wire | Press release
Management and technology consultancy BearingPoint announced today that it has internally promoted 13 new Partners across Europe. The promotions underline the firm’s ongoing success and growth and the ambitions defined in its Strategy 2025: put people in the center, outperform the market every year, and be in the top three in chosen areas of expertise.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210630005761/en/
Kiumars Hamidian, Managing Partner at BearingPoint, said: “It is a real pleasure welcoming 13 new Partners to our Partner-led firm. All of our new Partners have reached this important milestone based on their exceptional abilities, deep industry expertise, and their outstanding commitment to serving our clients. Promoting them is a demonstration of the success of our business, and it reflects our ambition manifested in our Strategy 2025.”
The new Partners at a glance:
Bjorn Ahlgren
Office: Stockholm/Sweden
With BearingPoint since: 2008
Education: Master’s in Industrial Economics
Business focus: Consumer goods and retail
“My ambition is to grow the Consumer Goods and Retail practice and strengthen the BearingPoint market footprint.”
Jan-Peter Baas
Office: Frankfurt/Germany
With BearingPoint since: 2004
Education: University of Applied Sciences, degree in Computer Sciences
Business focus: Government and public sector, specialized in IT architecture and software development
“I am looking forward to strengthening technical consulting and connecting business and IT in order to make innovative, technical solutions easier and more quickly accessible for the business success of our clients.”
Thomas Bagley
Office: Oslo/Norway
With BearingPoint since: 2018
Education: Bachelor’s in Mechanical Engineering and Master’s in Management
Business focus: M&A, cross-industry
“As Partner and head of M&A within BearingPoint Capital, I look forward to continuing to execute on the plan to become the preferred M&A advisor within the technology and software space in Europe.”
Franck Charlouty
Office: Paris/France
With BearingPoint since: 2004
Education: Civil Engineering degree
Business focus: Utilities - electricity / gas
“With climate change, utilities all around the world are facing unprecedented transformations and challenges. Thanks to more than 20 years of experience in the industry, my ambition is to help my French clients tackle those transformations and succeed in their goal to deliver more climate-friendly energy.”
Séverin de Crémiers
Office: Paris/France
With BearingPoint since: 2005
Education: Institute of Political Studies of Paris
Business focus: Government and public sector, Ministries of Economy, Ecology, Agriculture and Education
“With this new role as Partner, I aim to further assist public organizations in their journey toward more citizen-centric, resilient, and agile ways of delivering public services with a strong focus on the well-being of public servants.”
Sven Gerhardus
Office: Dusseldorf/Germany
With BearingPoint since: 2011
Education: Master’s in Business Administration
Business focus: Insurance with specific expertise in customer management (marketing, sales, service) and Salesforce and BSI CRM implementation
“As a Partner, I am committed to supporting our insurance industry clients in their transformation towards customer-centricity. Together with our technology partners, we optimize the customer experience of insurers. I will do everything to further strengthen the position of BearingPoint as the top address for management consulting.”
Annekatrin Mohr
Office: Frankfurt/Germany
With BearingPoint since: 2018
Education: Master’s in Political Sciences
Business focus: Digital customer management solutions for clients from the consumer goods and retail industry
“I aim to deliver innovative and data-driven customer engagement solutions to clients in the consumer goods and retail industry. I am passionate about taking customer-centricity to the next level by combining different perspectives: a solid business sense, organizational development, and future-proof technology.”
Paul Monnier
Office: Paris/France
With BearingPoint since: 2007
Education: National School of Computer Science and Applied Mathematics of Grenoble
Business focus: Technology, specialized in IT Infrastructure and operations advisory; leader of the cloud and IT sourcing community
“I will develop our CTO advisory and cybersecurity services, in particular by helping IT leaders benefit from market innovations impacting IT infrastructure and operations such as edge computing, AI operations, and sovereign cloud while keeping IT Infrastructure services resilient and secured.”
Alexander Odenthal
Office: Dusseldorf/Germany
With BearingPoint since: 2005
Education: CBS – Cologne Business School
Business focus: Finance transformation and corporate treasury
“My team and I will continue helping our clients to streamline treasury processes, facilitating efficient management of cash and liquidity as well as the identification, measurement, and mitigation of financial risk.”
Christian Opitz
Office: Frankfurt/Germany
With BearingPoint since: 2008
Education: Master’s in Business Administration and Master’s in Logistics and Supply Chain Management
Business focus: Cross-industry with a strong footprint in the consumer goods industries; specific expertise in combining management consulting projects with large ERP and process transformation programs
“As a Partner in our operations practice, my objective remains to combine management and IT consulting expertise to support clients end to end along their journeys to transform, optimize, and digitalize their processes. In particular, I am passionate about developing future-oriented integrated business planning concepts helping our clients to lower operations costs and risks to succeed in the volatile business environment.”
Stefan Savu
Office: Walldorf/Germany
With BearingPoint since: 2006
Education: Master’s in Business Information Technology
Business focus: Chemicals, life science and resources; specialized in logistics and large-scale SAP transformation projects
“My focus as a Partner in our Chemicals, Life Science and Resources segment is on the transformation of the supply chain of our clients. Throughout the years, I gained experience in the specialties of the life science industry and extended my area of expertise in warehousing and transportation with the associated areas of inbound and outbound logistics in combination with new technologies like SAP S/4HANA, RPA, and IoT. Here I am responsible for the design, development, and implementation of strategic, large-scale, global transformation programs, post-merger integrations, and divestiture projects.”
Manuel Schuler
Office: Frankfurt/Germany
With BearingPoint since: 2007
Education: Master's in Business Administration, International Business Development
Business focus: Digital and Strategy topics in the automotive industry with a specific focus on digital services, connectivity, new business models and customer experience
“My ambition is to guide our automotive clients through the challenges and disruptions of the digital transformation, re-invent their business models together with them and help them master the digital play.”
Melanie Tobler
Office: Munich/Germany
With BearingPoint since: 2007
Education: Master’s in International Management
Business focus: Leading and supporting large-scale SAP transformation programs in the automotive industry with a specific focus on preseries, logistics, and finance integration
“I am passionate about making people and projects successful! I am especially looking forward to leading our teams in accompanying our automotive clients to reach their next milestones in digitalization and process automation in the area of operations and the integration of finance and vehicle development.”
About BearingPoint
BearingPoint
is an independent management and technology consultancy with European roots and a global reach. The company operates in three business units: The first unit covers the advisory business with a clear focus on five key areas to drive growth across all regions. The second unit provides IP-driven managed services beyond SaaS and offers business critical services to its clients supporting their business success. The third unit provides the software for successful digital transformation. It is also designed to explore innovative business models with clients and partners by driving the financing and development of start-ups and leveraging ecosystems.
BearingPoint’s clients include many of the world’s leading companies and organizations. The firm has a global consulting network with more than 10,000 people and supports clients in over 70 countries, engaging with them to achieve measurable and sustainable success.
For more information, please visit:
Homepage: www.bearingpoint.com
LinkedIn: www.linkedin.com/company/bearingpoint
Twitter: @BearingPoint
View source version on businesswire.com: https://www.businesswire.com/news/home/20210630005761/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Merz Therapeutics Presents New Phase 2 PaiNT Data in Peripheral Neuropathic Pain at IASP 202626.10.2026 08:00:00 CET | Press release
Clinical and preclinical presentations reflect the company’s ongoing exploration of peripheral neuropathic pain Merz Therapeutics, a leading player in neurology-focused specialty pharma, today announced the presentation of new clinical and translational research in peripheral neuropathic pain (PNP) at the International Association for the Study of Pain (IASP) 2026 World Congress in Bangkok, Thailand, taking place from 26 to 30 October. The research spans new Phase 2 findings on incobotulinumtoxinA in postherpetic neuralgia (PHN) and post-surgical/post-traumatic neuropathic pain (PS/PTNP), as well as preclinical studies exploring potential biological mechanisms involved in effects of incobotulinumtoxinA on PNP models, highlighting Merz Therapeutics’ growing presence in neuropathic pain. In the PHN population of the Phase 2 PaiNT trial, results over 20 weeks favored incobotulinumtoxinA versus placebo treatment. In an exploratory analysis of average daily pain (ADP) intensity, the greates
Andersen Consulting tilføjer samarbejdsfirmaet TechSparq25.10.2026 06:09:00 CET | Pressemeddelelse
Andersen Consulting udvider sine kompetencer inden for teknologi og forretningstransformation gennem en samarbejdsaftale med TechSparq, en amerikansk virksomhed, der kombinerer strategi, commerce engineering og ai med praktisk implementering. TechSparq er et digitalt konsulenthus, der tilbyder strategi- og rådgivningstjenester, commerce engineering samt tjenester inden for ai og agentbaseret handel til virksomheder inden for detailhandel og forbrugsgoder, luksus og mode samt e-handel og direkte salg til forbrugere. Virksomheden har hovedkontor i Oregon og kombinerer strategisk planlægning med praktisk implementering for at hjælpe kunderne med at udvikle deres digitale initiativer, kundeoplevelse og driftsmodeller. "Vi etablerede vores virksomhed for at bygge bro mellem dem, der udvikler strategien, og dem, der har ansvaret for at føre den ud i livet," udtalte Dedrick Boyd, stifter af og administrerende direktør for TechSparq. "Vores samarbejde med Andersen Consulting giver os mulighed
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press release
Potential first-in-class GPC3 x 4-1BB bispecific achieves a 36% confirmed response rate at Phase 3 dose and favorable safety profile in heavily pretreated liver cancerBrain-penetrant PRMT5 inhibitor shows promising antitumor and CNS activity in the largest publicly shared MTAP-deficient datasetFirst clinical data of CEA-targeting ADC demonstrates encouraging and sustained responses in CEAhigh NSCLC BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to dise
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom